Stifel Financial’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,717
Closed -$459K 3376
2024
Q2
$459K Sell
5,717
-660
-10% -$60.3K ﹤0.01% 2679
2024
Q1
$588K Sell
6,377
-277
-4% -$26.6K ﹤0.01% 2511
2023
Q4
$702K Buy
+6,654
New +$671K ﹤0.01% 2367
2022
Q2
Sell
-2,006
Closed -$342K 3334
2022
Q1
$342K Sell
2,006
-8,243
-80% -$1.39M ﹤0.01% 2803
2021
Q4
$2.64M Buy
10,249
+436
+4% +$119K ﹤0.01% 1432
2021
Q3
$2.68M Sell
9,813
-4,884
-33% -$1.55M ﹤0.01% 1386
2021
Q2
$3.29M Sell
14,697
-887
-6% -$167K ﹤0.01% 1262
2021
Q1
$1.7M Buy
15,584
+12,531
+410% +$1.33M ﹤0.01% 1613
2020
Q4
$249K Sell
3,053
-1,215
-28% -$119K ﹤0.01% 2703
2020
Q3
$295K Sell
4,268
-2,468
-37% -$177K ﹤0.01% 2415
2020
Q2
$449K Buy
+6,736
New +$336K ﹤0.01% 2107

Other funds holding BNTX

Stifel Financial's BNTX Position: Q3 2024 in Review

Stifel Financial sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 5,717 shares — an estimated $459K sold.

Stifel Financial first reported a position in BNTX in Q2 2020 and held it in 11 quarters. The position peaked at $3.29M in Q2 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Stifel Financial reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Stifel Financial sold 5,717 BioNTech shares in Q3 2024, an estimated $459K.
  • Stifel Financial first reported a position in BioNTech in Q2 2020 and held it in 11 quarters.
  • Stifel Financial's BioNTech position peaked at $3.29M in Q2 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Stifel Financial's 13F filing for Q3 2024, filed 14 Nov 2024.